TUESDAY, June 17, 2025 (HealthDay News) — Receipt of a stimulant prescription for attention-deficit/hyperactivity disorder (ADHD) via telehealth is not associated with an increased risk for substance use disorder (SUD), according to a study published online June 11 in The American Journal of Psychiatry. Vinod Rao, M.D., Ph.D., from Massachusetts General Hospital in Boston, and […]
The post Prescribing ADHD Meds by Telehealth Does Not Alter Risk for Substance Use Disorder Overall first appeared on Physician’s Weekly.
